Michael S. Huh
501 Smyth Road
Ottawa, ON, Canada
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Journal: Frontiers in immunology
Published: September 21, 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Journal: Frontiers in immunology
Published: August 27, 2022
ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity.
Journal: PLoS biology
Published: October 01, 2019
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.
Journal: Journal for immunotherapy of cancer
Published: February 01, 2018
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies.
Journal: Molecular therapy oncolytics
Published: June 02, 2016
Stalled replication forks within heterochromatin require ATRX for protection.
Journal: Cell death & disease
Published: February 10, 2016
The sub-nucleolar localization of PHF6 defines its role in rDNA transcription and early processing events.
Journal: European journal of human genetics : EJHG
Published: January 19, 2016
Snf2h-mediated chromatin organization and histone H1 dynamics govern cerebellar morphogenesis and neural maturation.
Journal: Nature communications
Published: February 12, 2014
Loss of Atrx sensitizes cells to DNA damaging agents through p53-mediated death pathways.
Journal: PloS one
Published: August 30, 2012
Compromised genomic integrity impedes muscle growth after Atrx inactivation.
Journal: The Journal of clinical investigation
Published: March 07, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026